Berkshire Hathaway pulls out of AbbVie, Bristol Myers Squibb investments
It looks like Warren Buffett is sticking to ice cream and railroads for the moment.
The billionaire CEO of Berkshire Hathaway backed out of two major holdings in the pharma industry, Forexlive first reported, including a $410 million investment in AbbVie and a $324.4 million stake in Bristol Myers Squibb.
The move comes after Berkshire abandoned its Teva shares just last quarter, Bloomberg reported.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.